- ►diabetesjournals.org WT Cefalu, DJ Schneider, HE Carlson, P … - Diabetes Care, 2002 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—A total of 91 subjects were screened, subjected to
a 4-week drug washout, and randomized to daily treatment with glipizide GITS
(maximum 20 mg, n = 46) or metformin (maximum 2,550 mg, n = 45) as ... Cited by 24 - Related articles - BL Direct - All 5 versions
Y Chen, BE Sobel, DJ Schneider - Nutrition, metabolism, and cardiovascular diseases: …, 2002 - ncbi.nlm.nih.gov BACKGROUND AND AIM: Concentrations in blood of plasminogen activator inhibitor
type 1 (PAI-1) and circulating free (non-esterified) fatty acids (FFA) are
increased in diabetes and may accelerate atherosclerosis. We have shown ... Cited by 15 - Related articles - BL Direct
G Fanghänel, U Silva, L Sanchez-Reyes, D … - Revista de investigación clínica; organo del Hospital … - ncbi.nlm.nih.gov OBJECTIVE: To determine fibrinogen levels in obese patients with type 2 diabetes
and assess its changes with the use of metformin. METHODS: 60 obese patients
(BMI > 27) with type 2 diabetes were studied in an open, two phase, ... Cited by 16 - Related articles - BL Direct - All 3 versions
- ►ahajournals.org AKM Zaman, S Fujii, H Sawa, D Goto, N … - Circulation, 2001 - Am Heart Assoc Methods and Results—To determine whether hypofibrinolysis in blood and tissues
and its potential sequelae could be attenuated pharmacologically, we studied
genetically modified obese mice. By 10 weeks of age, obese mice exhibited ... Cited by 43 - Related articles - BL Direct - All 5 versions
WT Cefalu, A Bell-Farrow, ZQ Wang, D McBride … - Drug Development Research, 1998 - interscience.wiley.com Glipizide in a once daily formulation utilizing the gastrointestinal therapeutic
system (GITS) has been shown in preliminary studies to improve insulin
sensitivity as assessed with meal tolerance testing. To evaluate the ... Cited by 14 - Related articles - BL Direct - All 2 versions
TK Nordt, S Lutzi, J Ruef, K Peter, E Klar, W … - Thrombosis and haemostasis, 2001 - ncbi.nlm.nih.gov Human atherosclerotic lesions exhibit increased expression of plasminogen
activator inhibitor type-1 (PAI-1) that has been implicated in atherogenesis.
Although vascular smooth muscle cells are a predominant source of PAI-1 ... Cited by 14 - Related articles - BL Direct - All 2 versions
BE Sobel - Front Biosci, 2003 - bioscience.org Diabetes is characterized by impaired fibrinolysis. This phenomenon reflects
augmented concentrations of plasminogen activator inhibitor type-1 in tissues
and in blood. The derangement appears to depend in part on elevated ... Cited by 14 - Related articles - View as HTML - All 2 versions
[CITATION] Autoinhibitor of murine macrophage mediated oscidation of LDL by nitric oxide synthesis
